New methods to enhance interactions between biomolecules and small molecules
Bioorthogonal methods for unveiling chemical reactivity
This study is exploring new ways to improve how medicines work in the body by creating special chemicals that can easily attach to and detach from proteins, which could lead to better drug delivery and more effective treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Institute of Technology NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10800059 on NIH RePORTER |
What this research studies
This research focuses on developing innovative chemical techniques that allow for precise interactions between biomolecules and small molecules within biological systems. By utilizing N-oxides, the project aims to create reversible modifications that can enhance the functionality of proteins and small molecules. The approach involves synthesizing these reagents through a rapid reaction process and controlling their attachment and release in a biological context. Patients may benefit from advancements in drug delivery and targeted therapies resulting from these new chemical methods.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated through enhanced drug delivery mechanisms.
Not a fit: Patients with conditions that do not involve biomolecular interactions or require traditional treatment methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and targeted drug delivery systems for various diseases.
How similar studies have performed: Other research has shown promise in using bioorthogonal chemistry for drug delivery, indicating that this approach has potential for success.
Where this research is happening
Atlanta, United States
- Georgia Institute of Technology — Atlanta, United States (Active)
Researchers
- Principal investigator: Kim, Justin — Georgia Institute of Technology
- Study coordinator: Kim, Justin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.